Redmile Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $416K | Sell |
112,168
-885,067
| -89% | -$3.28M | 0.04% | 47 |
|
|
2025
Q1 | $3.22M | Sell |
997,235
-199,675
| -17% | -$645K | 0.3% | 44 |
|
|
2024
Q4 | $6.67M | Sell |
1,196,910
-65,180
| -5% | -$363K | 0.46% | 41 |
|
|
2024
Q3 | $13.6M | Buy |
1,262,090
+188,655
| +18% | +$2.04M | 0.8% | 33 |
|
|
2024
Q2 | $22.5M | Sell |
1,073,435
-187,992
| -15% | -$3.95M | 1.36% | 29 |
|
|
2024
Q1 | $40.2M | Buy |
+1,261,427
| New | +$40.2M | 1.48% | 25 |
|